Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
about
Oral insulin delivery: how far are we?Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine releasePreparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: the improvement of Peyer's patch targeting using a polyplex-loaded liposomes.N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.Biomaterials for nanoparticle vaccine delivery systems.Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene deliveryOcular delivery of cyanidin-3-glycoside in liposomes and its prevention of selenite-induced oxidative stress.Interplaying factors that effect multiple sclerosis causation and sustenance.The potential of chitosan for the oral administration of peptides.Chemical modification and formulation approaches to elevated drug transport across cell membranes.Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.Chitosan nanoparticles for oral drug and gene delivery.Nanoparticle strategies for the oral delivery of insulin.Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.Nanoparticles as protein and gene carriers to mucosal surfaces.Critical evaluation of permeation enhancers for oral mucosal drug delivery.Review of antimicrobial and antioxidative activities of chitosans in food.Strategies for non-invasive delivery of biologics.Application of polysaccharides for surface modification of nanomedicines.Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.Nanocarriers for oral drug delivery.Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.In vitro evaluation of quaternized polydimethylaminoethylmethacrylate sub-microparticles for oral insulin delivery.Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System.Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery.Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by chemical modification with polysaccharide and attenuation effects on radiation-induced inflammatory cytokine expression in vitro.Effect of Quaternary Ammonium Carboxymethylchitosan on Release Rate In-vitro of Aspirin Sustained-release Matrix Tablets.N-trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery.Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine.Functionalized and graft copolymers of chitosan and its pharmaceutical applications.Eudragit® L100/N-trimethylchitosan chloride microspheres for oral insulin delivery.Endotoxins affect diverse biological activity of chitosans in matters of hemocompatibility and cytocompatibility.Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology.Progress in the formulation and delivery of somatostatin analogs for acromegaly.Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.
P2860
Q24632900-7675A672-D10D-49D5-BEE6-5EB6AD223D21Q28479064-D4100224-08E9-4BB6-93CA-F6DAA9B13CEBQ33414140-E747FC66-935A-4790-BB66-41B2C2FC87B7Q33782651-8293E908-CBCE-46C8-A32E-F624E836AC9CQ33985218-F98B6F0F-00AB-46AC-93A2-4D2B7B082A17Q34050685-048B5DF2-F61F-47E6-9F70-164313513B61Q34345012-C0A15EDA-8D22-40C0-9E9D-C0B7A20247F7Q35031451-634F0542-D87E-4E46-82D7-C9CC7605007FQ35688220-3B661DA5-1BD2-4786-9D8A-2853F437C7F5Q35783250-352A3F2A-ADDD-4399-9BCB-4EE2DBFCDE83Q35825309-4F1E16E0-213C-419B-9031-0DF832EF4C79Q36316822-5DE20FD6-E13D-4F59-806E-ED8EEA3AD336Q36527751-A301DEF0-0021-4B1C-99F5-6F8B6A3FB82CQ36548827-0B97356D-FD60-4754-857C-A16B4E9FA153Q36920450-E59438C4-1369-4D61-BAB4-22CDC1F216F4Q37039026-B20C88F9-DE96-4803-AD17-B0B732B74A9FQ37044440-BADD04AE-0FFC-440C-B85C-3C7B93DFF5D4Q37331802-0F1D22F0-01D1-476D-9D52-DF8878CABC69Q37575468-7934E374-5691-43C9-94CC-0761092273A9Q37786660-0E089FCA-ED16-415E-B8FD-3050A0FF48D4Q38013190-FFC11447-537C-4604-8054-4EA9385DBBFDQ38074443-83B59987-05BD-447A-9344-86A0E4BDD775Q38100561-8D9A725C-0EC1-4E8B-B6B2-88D9593A6349Q38101960-42AC9CC3-1A8C-45F1-814B-603290A5F569Q38653884-33BCA5E1-0610-4ED5-B450-5C555731C878Q38826782-ABAB95E7-0AD9-4085-B8F3-63B9F472A1AEQ39327596-D7612B5C-B971-4A40-ACCF-B99082DC5746Q41191759-B87D462E-4A4E-4A33-933B-47A7388A6538Q41364332-71624C8E-99E4-46A9-9998-E4FEBCE5B0DBQ42797716-A8400BF9-E362-49A1-A33B-84E09D78CA53Q42927420-834A2322-59DE-49D8-9DDC-9DE723C3DC92Q43260819-89E5AC85-DE49-4162-A9AF-D8F254BBF8CCQ44143118-12045174-6B1D-4E84-B731-2B4BD27998D5Q44187608-70BF0862-D5FA-4976-B8CF-3560DFCE6F30Q44867110-6793944F-576C-4FD9-8CB5-26F48626F53BQ45382343-D3F80B19-ABD1-44E3-8C28-C88B1C82EF69Q46232789-1EDA5F12-46D5-4C88-A10D-4393A8A8653DQ46343786-8B00FF82-E927-42E7-BC61-1132607A33CEQ47928226-0AFB1775-CE12-4F6C-9EAA-9920E6EC2888Q48626221-41F56904-7044-46FC-A6D8-1C6605D69F38
P2860
Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Trimethylated chitosan as poly ...... ral delivery of peptide drugs.
@ast
Trimethylated chitosan as poly ...... ral delivery of peptide drugs.
@en
type
label
Trimethylated chitosan as poly ...... ral delivery of peptide drugs.
@ast
Trimethylated chitosan as poly ...... ral delivery of peptide drugs.
@en
prefLabel
Trimethylated chitosan as poly ...... ral delivery of peptide drugs.
@ast
Trimethylated chitosan as poly ...... ral delivery of peptide drugs.
@en
P2093
P1476
Trimethylated chitosan as poly ...... ral delivery of peptide drugs.
@en
P2093
Junginger HE
Verheijden JH
Verhoef JC
van der Merwe SM
P304
P356
10.1016/J.EJPB.2004.03.023
P407
P577
2004-09-01T00:00:00Z